| The foregut in cystic fibrosis C Vélez, I Neuringer, SJ Schwarzenberg Pediatric Pulmonology 59, S61-S69, 2024 | | 2024 |
| Heterogeneity in Reported Side Effects Following Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Trikafta Experiences at a Quaternary CF Care Center L Papadakis, T Stander, J Mombourquette, C Richards, L Yonker, ... | | 2024 |
| Host DNA Depletion Enables Successful Shotgun Metagenomics of Previously Frozen Non-cryo-Preserved Respiratory Samples M Kim, RC Parrish, V Shah, MC Ross, J Cormier, A Baig, CY Huang, ... D101. UNCOVERING THE METABOLIC AND GENETIC UNSOLVED MYSTERIES IN ASTHMA …, 2024 | | 2024 |
| Comparative Analysis of Antibiotic Resistance Gene Profiles in Adults With Cystic Fibrosis With and Without Diabetes L Brenner, M Kim, SL Bringhurst, J Viera, C Richards, L Sicilian, ... C101. UNDERSTANDING LUNG IMMUNITY IN THE BATTLE AGAINST INFECTION, A6693-A6693, 2024 | | 2024 |
| Trikafta Use in NCFB Patients With a Single Disease Causing CFTR Mutation and Evidence of CFTR Dysfunction C Richards, L Papadakis, IP Neuringer, H Lee, L Bringhurst, L Sicilian D97. FEELING STUCK? MECHANISMS OF MUCOCILIARY (DYS) FUNCTION, A7267-A7267, 2024 | | 2024 |
| Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF KJ Scully, L Brenner, K Martin, M Ruazol, GS Sawicki, A Uluer, ... Frontiers in Endocrinology 15, 1293709, 2024 | 1 | 2024 |
| Host DNA depletion on frozen human respiratory samples enables successful metagenomic sequencing for microbiome studies M Kim, RC Parrish, VS Shah, M Ross, J Cormier, A Baig, CY Huang, ... Research Square, 2024 | | 2024 |
| Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis–Related Diabetes JS Sherwood, LE Castellanos, MY O’Connor, CA Balliro, MA Hillard, ... Diabetes care 47 (1), 101-108, 2024 | 5 | 2024 |
| 578 Assessing continuous glucose monitoring for prediction of clinical outcomes and development of cystic fibrosis–related diabetes in adults with cystic fibrosis K Scully, L Brenner, K Martin, M Ruazol, G Sawicki, A Uluer, I Neuringer, ... Journal of Cystic Fibrosis 22, S306-S307, 2023 | | 2023 |
| Delayed and Attenuated Antibody Responses to Coronavirus Disease 2019 Vaccination with Poor Cross-Variant Neutralization in Solid-Organ Transplant Recipients—A Prospective … MY Liew, JI Mathews, A Li, R Singh, SA Jaramillo, ZF Weiss, K Bowman, ... Open Forum Infectious Diseases 10 (8), ofad369, 2023 | 3 | 2023 |
| Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response MA Villavicencio, SS Li, AM Leifer, JL Gustafson, A Osho, S Wolfe, Y Raz, ... JTCVS open 14, 602-614, 2023 | | 2023 |
| Dysglycemia Affects the Airway Microbiome in Cystic Fibrosis L Brenner, J Viera, M Kim, L Bringhurst, C Richards, IP Neuringer, ... C32. THE AIRWAY BATTLE FOR DOMINANCE: IMMUNE SYSTEM VERSUS INFECTIONS, A4781 …, 2023 | | 2023 |
| Take on transplant: human-centered design of a patient education tool to facilitate informed discussions about lung transplant among people with cystic fibrosis AL Hartzler, LE Bartlett, MR Hobler, N Reid, JB Pryor, SG Kapnadak, ... Journal of the American Medical Informatics Association 30 (1), 26-37, 2023 | 3 | 2023 |
| Focus: Antimicrobial resistance: Inhaled bacteriophage therapy for multi-drug resistant Achromobacter F Winzig, S Gandhi, A Lee, S Würstle, GL Stanley, I Capuano, I Neuringer, ... The Yale Journal of Biology and Medicine 95 (4), 413, 2022 | 8 | 2022 |
| Supplemental oxygen alters the airway microbiome in cystic fibrosis J Vieira, S Jesudasen, L Bringhurst, HY Sui, L McIver, K Whiteson, ... Msystems 7 (5), e00364-22, 2022 | 4 | 2022 |
| 9 Automated insulin delivery with the iLet bionic pancreas for the management of cystic fibrosis–related diabetes J Sherwood, L Castellanos, M Sands, C Balliro, M Hillard, S Gaston, ... Journal of Cystic Fibrosis 21, S6-S7, 2022 | 4 | 2022 |
| Continuous glucose monitoring and HbA1c in cystic fibrosis: clinical correlations and implications for CFRD diagnosis KJ Scully, JS Sherwood, K Martin, M Ruazol, P Marchetti, M Larkin, ... The Journal of Clinical Endocrinology & Metabolism 107 (4), e1444-e1454, 2022 | 29 | 2022 |
| Detectable Serum Concentration With Prophylactic Inhaled Tobramycin in Lung Transplant Recipients J Kim, G Waldman, CR Marks, RG Gandhi, J Palafox, IP Neuringer, ... The Journal of Heart and Lung Transplantation 41 (4), S413, 2022 | 1 | 2022 |
| Tolerability of Extended Multi-Drug Fungal Prophylaxis After Lung Transplant KE Rechenberg, G Waldman, CR Marks, RG Gandhi, J Palafox, ... The Journal of Heart and Lung Transplantation 41 (4), S413-S414, 2022 | | 2022 |
| The effects of ivacaftor on bone density and microarchitecture in children and adults with cystic fibrosis MS Putman, LB Greenblatt, M Bruce, T Joseph, H Lee, G Sawicki, A Uluer, ... The Journal of Clinical Endocrinology & Metabolism 106 (3), e1248-e1261, 2021 | 24 | 2021 |
